AirSculpt Technologies (NASDAQ:AIRS) Announces Quarterly Earnings Results

AirSculpt Technologies (NASDAQ:AIRS) issued its earnings results on Monday. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.02 by ($0.01), FiscalAI reports. AirSculpt Technologies had a negative return on equity of 6.07% and a negative net margin of 7.79%.The business had revenue of $42.90 million for the quarter, compared to analyst estimates of $44.14 million.

Here are the key takeaways from AirSculpt Technologies’ conference call:

• Business stabilization continued: Q2 revenue was $42.9 million, down 2.5% year over year, but same-center case volume rose 1%, marking a second consecutive quarter of case growth. Same-center sales improved 21 percentage points year over year and were roughly flat for the first half.
• AirSculpt is expanding its procedure portfolio to address GLP-1-related body-contouring needs. Skin excisions reached more than 200 procedures in Q2, while the new AlloClae partnership is expected to begin rolling out later this quarter and is not yet included in guidance.
• Management said consumer trends softened in June and continued into July, prompting expectations for comparable Q3 revenue to decline by a single-digit percentage. Full-year revenue guidance was reaffirmed at the lower end of the prior range, while adjusted EBITDA guidance was reduced to $12 million–$14 million due partly to an additional $5 million marketing investment.
• Higher marketing investment has yet to fully translate into efficiency, with customer acquisition cost increasing to approximately $3,500 per case from roughly $2,900 a year ago. Adjusted EBITDA declined to $4.9 million, or 11.5% of revenue, from $5.8 million in the prior-year quarter.
• Liquidity and debt metrics improved, with approximately $24 million of available liquidity at quarter-end, $44 million of gross debt, and a term-loan maturity extension to November 2027. Management also reported roughly $20 million raised through its ATM program year to date and $13 million of debt repayment.

AirSculpt Technologies Trading Down 1.9%

NASDAQ AIRS traded down $0.06 during trading hours on Wednesday, reaching $3.15. The company’s stock had a trading volume of 729,351 shares, compared to its average volume of 1,678,039. The firm has a fifty day simple moving average of $4.65 and a 200-day simple moving average of $3.56. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.75 and a quick ratio of 0.75. AirSculpt Technologies has a 52 week low of $1.51 and a 52 week high of $12.00. The stock has a market cap of $222.23 million, a P/E ratio of -17.52 and a beta of 2.33.

Hedge Funds Weigh In On AirSculpt Technologies

Several large investors have recently modified their holdings of the business. BNP Paribas Financial Markets grew its stake in shares of AirSculpt Technologies by 239.5% in the third quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company’s stock worth $48,000 after purchasing an additional 4,199 shares during the last quarter. Intech Investment Management LLC acquired a new position in AirSculpt Technologies during the 3rd quarter worth about $80,000. Brevan Howard Capital Management LP bought a new stake in shares of AirSculpt Technologies in the 3rd quarter valued at about $83,000. Jane Street Group LLC acquired a new stake in shares of AirSculpt Technologies in the second quarter valued at about $60,000. Finally, Creative Planning lifted its stake in shares of AirSculpt Technologies by 32.2% in the second quarter. Creative Planning now owns 13,225 shares of the company’s stock worth $64,000 after acquiring an additional 3,224 shares during the period. Institutional investors own 91.54% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the stock. Weiss Ratings upgraded shares of AirSculpt Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, July 1st. Leerink Partners set a $4.50 target price on shares of AirSculpt Technologies in a research note on Thursday, May 14th. Finally, Wall Street Zen upgraded shares of AirSculpt Technologies from a “hold” rating to a “buy” rating in a report on Saturday, June 27th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, AirSculpt Technologies presently has an average rating of “Reduce” and an average price target of $4.50.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.